학술논문

HSP27 is a partner of JAK2-STAT5 and a potential therapeutic target in myelofibrosis
Document Type
article
Source
Nature Communications, Vol 9, Iss 1, Pp 1-13 (2018)
Subject
Science
Language
English
ISSN
2041-1723
Abstract
Myelofibrosis is a chronic degenerative disorder characterized by progressive bone marrow fibrosis. Here, the authors show that the chaperone HSP27 contributes to myelofibrosis via regulation of the JAK2/STAT5 pathway, and that antisense oligonucleotides targeting HSP27 are effective in two mouse models of the disease